Lilly announces three acquisitions to build infectious disease portfolio - PR Newswire
Lilly announces three acquisitions to build infectious disease portfolio PR Newswire Eli Lilly spending up to $3.8 billion to buy vaccine makers Axios Lilly spends nearly $4B to acquire three vaccine developers Indianapolis Business Journal Three vaccine biotechs to be bought by Lilly for up to $3.8B Endpoints News Exclusive | Lilly Agrees to Buy Trio of Vaccine Developers WSJ
YesNo saves this item as an on-site live signal so search users can understand how it connects to prediction markets and incubation topics.
If later reporting creates a clear deadline, official source, or verifiable outcome, the public event can become a tradable Yes/No question.
This item has a verifiable event angle that can be monitored for a Yes/No prediction market.